OTOFA, ear solution in drops bottle, 10 ml
Active ingredients: Rifamycin, Rifamycin sodium
Commercialized according to BDPMDispensing in France: Prescription only
Solution dropsbottle, 10 mlauriculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OTOFA, solution auriculaire en gouttes
- Pharmaceutical form
- solution gouttes
- Route of administration
- auriculaire
- Presentation description
- 1 flacon(s) en verre de 10 ml avec compte-gouttes
- Marketing authorisation holder
- BOUCHARA-RECORDATI
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1986
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62494470CIP73280520CIP133400932805204Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RIFAMYCINEsolution | 2 000 000 UI · 100 ml | FT |
| RIFAMYCINE SODIQUEsolution | 2,6 g · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.